Area of research
Molecular Biology · Oncology
Research interest
Research interests include Lung Cancer Research Studies, Melanoma and MAPK Pathways, Cancer Mechanisms and Therapy, and Lung Cancer Treatments and Mutations.
Lazertinib Versus Osimertinib in Previously Untreated EGFR-Mutant Advanced NSCLC: A Randomized, Double-Blind, Exploratory Analysis From MARIPOSA
A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma
Subcutaneous amivantamab vs intravenous amivantamab, both in combination with lazertinib, in refractory <i>EGFR</i>-mutated, advanced non-small cell lung cancer (NSCLC): Primary results, including overall survival (OS), from the global, phase 3, randomized controlled PALOMA-3 trial.
OONO–/MMP2/MMP9 pathway-mediated apoptosis of porcine granulosa cells is associated with DNA damage
Dietary folic acid supplementation improves semen quality and spermatogenesis through altering autophagy and histone methylation in the testis of aged broiler breeder roosters
Application of neurally adjusted ventilatory assist in ventilator weaning of infants ventilator weaning
A New Compound with Increased Antitumor Activity by Cotargeting MEK and Pim-1
Current Development Status of MEK Inhibitors